Infrequent physician use of implantable cardioverter-defibrillators risks patient safety

Heart

Volumn 97, Issue 20, 2011, Pages 1655-1660

  Lyman, Stephen ^a   Sedrakyan, Art ^b   Do, Huong ^a   Razzano, Renee ^b   Mushlin, Alvin I ^b  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEART TAMPONADE; HEMATOMA; HOSPITAL READMISSION; HUMAN; IMPLANTATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PNEUMOTHORAX; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL INFECTION; UNITED STATES;

AGED; ARRHYTHMIAS, CARDIAC; CLINICAL COMPETENCE; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; NEW YORK; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 80053185106     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2011.226282     Document Type: Article

References (33)

1. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40. (Pubitemid 26428217)
2. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.
3. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure. N Engl J Med 2005;352:225-37. (Pubitemid 40110811)
4. Desai AS, Fang JC, Maisel WH, et al. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA 2004;292:2874-9. (Pubitemid 39628235)
5. Nanthakumar K, Epstein AE, Kay GN, et al. Prophylactic implantable cardioverterdefibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol 2004;44:2166-72. (Pubitemid 39576036)
6. Passman R, Subacius H, Ruo B, et al. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. Arch Intern Med 2007;167:2226-32. (Pubitemid 350106743)
7. Zwanziger J, Hall WJ, Dick AW, et al. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 2006;47:2310-18. (Pubitemid 43795065)
8. Centers for Medicare and Medicaid Service. Medicare coverage center, 2010. http://www.cms.gov/center/coverage.asp (accessed 7 May 2010).
9. Food and Drug Administration. Postmarket performance and safety, 2010. http:// www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHTransparency/ucm199909.htm (accessed 7 May 2010).
10. Curtis AB, Ellenbogen KA, Hammill SC, et al. Clinical competency statement: training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. Heart Rhythm 2004;1:371-5. (Pubitemid 39549773)
11. Al-Khatib SM, Lucas FL, Jollis JG, et al. The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J Am Coll Cardiol 2005;46: 1536-40. (Pubitemid 41446191)
12. Freeman JV, Wang Y, Curtis JP, et al. The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry. J Am Coll Cardiol 2010;56:1133-9.
13. Hannan EL, Racz M, Ryan TJ, et al. Coronary angioplasty volumeeoutcome relationships for hospitals and cardiologists. JAMA 1997;277:892-8. (Pubitemid 27123949)
14. Lyman S, Jones EC, Bach PB, et al. The association between hospital volume and total shoulder arthroplasty outcomes. Clin Orthop Relat Res 2005;(432):132-7. (Pubitemid 40316172)
15. Reynolds MR, Cohen DJ, Kugelmass AD, et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 2006;47:2493-7. (Pubitemid 43866387)
16. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83. (Pubitemid 34984635)
17. Curtis LH, Al-Khatib SM, Shea AM, et al. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA 2007;298:1517-24. (Pubitemid 47529385)
18. Yarnoz MJ, Curtis AB. Sex-based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies: effectiveness and use. Cardiol Rev 2006;14:292-8. (Pubitemid 44624588)
19. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27. (Pubitemid 128456396)
20. Lin G, Nishimura RA, Gersh BJ, et al. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy. Heart 2009;95:709-14.
21. Khavandi A, Hamilton S, Fitzpatrick A, et al. Cardiologists should have basic surgical skills training. Heart 2010;96:741-2.
22. Parsonnet V, Bernstein AD, Lindsay B. Pacemaker-implantation complication rates: an analysis of some contributing factors. J Am Coll Cardiol 1989;13:917-21. (Pubitemid 19087915)
23. Tobin K, Stewart J, Westveer D, et al. Acute complications of permanent pacemaker implantation: their financial implication and relation to volume and operator experience. Am J Cardiol 2000;85:774-6, A9.
24. US Census Bureau. New Yorkdcounty. GCT-T1 population estimates, 2010. http://factfinder.census.gov (accessed 7 May 2010).
25. Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003;349:2117-27. (Pubitemid 37464537)
26. Dimick JB, Cowan JA Jr, Stanley JC, et al. Surgeon specialty and provider volumes are related to outcome of intact abdominal aortic aneurysm repair in the United States. J Vasc Surg 2003;38:739-44. (Pubitemid 37254801)
27. Katz JN, Barrett J, Mahomed NN, et al. Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am 2004;86-A:1909-16. (Pubitemid 39223458)
28. Nordin P, van der Linden W. Volume of procedures and risk of recurrence after repair of groin hernia: national register study. BMJ 2008;336:934-7. (Pubitemid 351632020)
29. Callahan MA, Christos PJ, Gold HT, et al. Influence of surgical subspecialty training on in-hospital mortality for gastrectomy and colectomy patients. Ann Surg 2003;238:629-36; discussion 636-9.
30. Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med 2002;137:511-20. (Pubitemid 35024623)
31. Holt PJ, Poloniecki JD, Loftus IM, et al. Epidemiological study of the relationship between volume and outcome after abdominal aortic aneurysm surgery in the UK from 2000 to 2005. Br J Surg 2007;94:441-8. (Pubitemid 46624722)
32. Holt PJ, Poloniecki JD, Loftus IM, et al. The relationship between hospital case volume and outcome from carotid endartectomy in England from 2000 to 2005. Eur J Vasc Endovasc Surg 2007;34:646-54. (Pubitemid 350056377)
33. Hammill S, Phurrough S, Brindis R. The National ICD Registry: now and into the future. Heart Rhythm 2006;3:470-3.